Gestational age, weeks, median (range) |
25 (21–29) |
26 (24–29) |
0.06 |
Birth weight, g, median (range) |
720 (340–990) |
760 (620–995) |
0.06 |
Maternal chorioamnionitis, n (%) |
21 (70) |
5 (28) |
0.005 |
Lack of antenatal steroid therapy, n (%) |
19 (63) |
4 (22) |
0.006 |
Hypotension requiring inotropic support, n (%) |
22 (73) |
2 (11) |
<0.001 |
Tachycardia, n (%) |
16 (53) |
3 (17) |
0.01 |
Oliguria, n (%) |
11 (37) |
1 (5.5) |
0.01 |
Surfactant treatment, n (%) |
16 (53) |
6 (33) |
0.14 |
Repeated dosage of surfactant (%) |
9 (30) |
0 (0) |
0.001 |
High frequency ventilation, n (%) |
9 (30) |
1 (5) |
0.003 |
Cord blood gas deficit ≥−12 mmol/L, n (%) |
7 (14.6) |
4 (8.3) |
0.92 |
Need of invasive ventilation, n (%) |
26 (54.2) |
15 (31.3) |
0.75 |
Metabolic acidosis, pH < 7.35, BD > −4, n (%) |
7 (14.6) |
4 (8.3) |
0.92 |
Respiratory acidosis, pH < 7.35, PCO2 > 45 mmHg, n (%) |
26 (54.2) |
15 (31.3) |
0.75 |
Maximum PIP, >18 cm H2O, n (%) |
22 (18–24) |
22 (18–24) |
0.62 |
FiO2 at admission, >40%, n (%) |
26 (54.2) |
15 (31.3) |
0.75 |